Moving from ICS/LABA to single inhaler triple therapy in COPD
Moving from ICS/LABA to single inhaler triple therapy in COPD -
Dr Neil Greening, a respiratory consultant, discusses the shift in COPD management from ICS/LABA to single inhaler triple therapy, and how in implementing proactive strategies, including pulmonary rehabilitation and patient-initiated follow-ups, healthcare professionals can better manage COPD.
Talk to us
Request a call or meeting with your local Chiesi representative at a time which suits you.
Order training inhalers
Support your patients with their inhaler technique by ordering placebo training inhalers directly from Chiesi.
Sign up for updates
Want to hear more from Chiesi? Opt-in to receive updates on Chiesi Air products and services.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Chiesi Limited on 0800 0092329 (UK) or PV.UK@Chiesi.com.